`
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`
`
`LUPIN LTD. and LUPIN PHARMACEUTICALS, INC.
`Petitioner,
`
`v.
`
`HORIZON THERAPEUTICS, INC.
`Patent Owner
`
`
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`
`
`PETITIONER’S MOTION FOR PRO HAC VICE
`ADMISSION OF ROBERT V. CERWINSKI
`
`
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`Petitioners Lupin Ltd. and Lupin Pharmaceuticals, Inc. respectfully request
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`
`
`
`the pro hac vice admission of Robert V. Cerwinski in this proceeding, IPR2016-
`
`00829, U.S. Patent No. 9,095,559 B2 (“the ’559patent”), pursuant to 37 C.F.R. §
`
`42.10(c). Patent Owner does not oppose this motion.
`
`I.
`
`THE REQUEST IS TIMELY
`
`As stated in the Board’s April 8, 2016, Notice of Filing Date, any motion for
`
`pro hac vice admission must be filed in accordance with the guidance specified in
`
`the “Order Authorizing Motion for Pro Hac Vice Admission,” entered in Case
`
`IPR2013-00639 (Paper 7). (“PHV Admission Order”). According to that
`
`guidance, pro hac vice motions can be filed no sooner than (21) days after service
`
`of the Petition. This pro hac vice motion is filed more than 21 days after the
`
`service of the Petition and is therefore timely.
`
`II.
`
`STATEMENT OF FACTS
`
`As required by the PHV Admission Order, the following statement of facts
`
`shows that there is good cause for the Board to recognize Mr. Cerwinski pro hac
`
`vice. An affidavit by Mr. Cerwinski, containing the required statements and
`
`information, is submitted herewith as Exhibit 1024.
`
`- 1 -
`
`
`
`Case IPR2016-00829
`Patent 9,095,559
`Elizabeth J. Holland, lead counsel for Petitioners Lupin Ltd. and
`
`1.
`
`Lupin Pharmaceuticals, Inc. in this proceeding, is a registered practitioner holding
`
`Registration No. 47,657.
`
`2.
`
`Cynthia Lambert Hardman, back-up counsel for Petitioners Lupin Ltd.
`
`and Lupin Pharmaceuticals, Inc. in this proceeding, is a registered practitioner
`
`holding registration No. 53,179.
`
`3. Mr. Cerwinski is a partner with Goodwin Procter LLP.
`
`4. Mr. Cerwinski is an experienced litigating attorney. Mr. Cerwinski
`
`has been litigating patent cases for nearly nineteen years. Mr. Cerwinski has been
`
`practicing law since 1997 and has extensive experience litigating patent
`
`infringement cases in many different district courts across the United States.
`
`5. Mr. Cerwinski’s experience in patent litigation matters includes patent
`
`jury trials, including opening statements, closing arguments, presentation of non-
`
`expert and expert-testimony, arguing Markman hearings, patent summary
`
`judgment proceedings, and other patent-related hearings and pleadings concerning,
`
`inter alia, patent validity and infringement issues. Mr. Cerwinski has also
`
`represented clients’ appeals before the Court of Appeals for the Federal Circuit
`
`resulting from cases tried by Mr. Cerwinski and in other cases.
`
`6. Mr. Cerwinski has an established familiarity with the subject matter at
`
`issue in this proceeding. Specifically, Mr. Cerwinski represents that he has
`
`
`
`- 2 -
`
`
`
`Case IPR2016-00829
`Patent 9,095,559
`reviewed the Petition and accompanying exhibits filed in this matter and all other
`
`papers associated with this proceeding. As part of this proceeding, Mr. Cerwinski
`
`has studied the ’559 patent. Mr. Cerwinski is also counsel of record in litigation in
`
`which the ’559 patent, as well as patents related to the ’559 patent, and other
`
`patents owned by Horizon Therapeutics, Inc. related to methods of using glyceryl
`
`tri-[4-phenylbutyrate] to treat subjects with urea cycle disorders are being asserted.
`
`Horizon Therapeutics, Inc. v. Lupin Ltd., 1-15-cv-07624, 1-16-cv-04438(D.N.J.)
`
`(currently stayed). He therefore has extensive knowledge of the ’559 patent and of
`
`the cited prior art.
`
`7. Mr. Cerwinski is a member in good standing of the Bar of the State of
`
`New York.
`
`8. Mr. Cerwinski has never been suspended or disbarred from practice
`
`before any court or administrative body.
`
`9.
`
`No application of Mr. Cerwinski for admission to practice before any
`
`court or administrative body has ever been denied.
`
`10. No sanctions or contempt citations have been imposed against Mr.
`
`Cerwinski by any court or Administrative Body.
`
`
`
`11. Mr. Cerwinski has read and will comply with the Office Patent Trial
`
`Practice Guide and the Board’s Rules of Practice for Trials set forth in part 42of 37
`
`C.F.R.
`
`
`
`- 3 -
`
`
`
`Case IPR2016-00829
`Patent 9,095,559
`12. Mr. Cerwinski understands that he will be subject to the USPTO Code
`
`of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary
`
`jurisdiction under 37 C.F.R. § 11.19(a).
`
`13. Mr. Cerwinski has applied to appear pro hac vice in the following
`
`proceedings before the Office in the last three years: IPR2015-01566 (granted),
`
`IPR2015-01571 (action terminated before ruling), IPR2015-01572 (action
`
`terminated before ruling), IPR2015-01570 (action terminated before ruling),
`
`IPR2015-01733 (action terminated before ruling), and IPR2015-01744 (action
`
`terminated before ruling), and IPR2016-01614 (pending).
`
`14. This motion was filed no sooner than 21 days after service of the
`
`Petition in this proceeding, which occurred on April 1, 2016.
`
`III. CONCLUSION
`
`For the foregoing reasons, Petitioner respectfully requests that the Board
`
`admit Robert V. Cerwinski pro hac vice in this proceeding.
`
`
`
`Dated: December 22, 2016
`
`
`
`Respectfully submitted,
`
`/Elizabeth J. Holland/
`Elizabeth J. Holland (Reg. No. 47,657)
`Cynthia Lambert Hardman (Reg. No.
`53,179)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`(212) 813-8800 (telephone)
`- 4 -
`
`
`
`Case IPR2016-00829
`Patent 9,095,559
`
`(212) 355-3333 (facsimile)
`
`
`
`Counsel for Petitioners
`
`
`
`- 5 -
`
`
`
`Case IPR2016-00829
`Patent 9,095,559
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that PETITIONER’S MOTION FOR PRO HAC
`
`VICE ADMISSION OF ROBERT V. CERWINSKI and Exhibit 1024 referenced
`
`herein (AFFIDAVIT OF ROBERT V. CERWINSKI IN SUPPORT OF MOTION
`
`FOR PRO HAC VICE ADMISSION) were served electronically via email on
`
`December 22, 2016 on the following:
`
`James B. Monroe (lead counsel, Reg. No. 33,971)
`Maureen D. Queler (backup counsel, Reg. No. 61,879)
`FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP
`James.monroe@finnegan.com
`Maureen.queler@finnegan.com
`
`
`
`Lauren L. Stevens, Ph.D (backup counsel, Reg. No. 36,691)
`Horizon Pharma USA, Inc.
`lstevens@horizonpharma.com
`
`
`
`Matthew Phillips (backup counsel, Reg. No. 43,403)
`Renaissance IP Law Group LLP
`matthew.phillips@renaissanceiplaw.com
`
`/Cynthia Lambert Hardman/
`Cynthia Lambert Hardman
`
`
`
`6
`
`
`
`
`Dated: December 22, 2016